ArticleBiomedicines2022

Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem.

Zrinka Sertić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.